Kóczián Kristóf
neuropsychiatry business leaderMale0.0Global Dominance: 0.00%
Kóczián Kristóf is the head of the neuropsychiatry business unit at Richter Gedeon Nyrt. and has highlighted the commercial success of cariprazine, which became one of the top-selling CNS medications globally within just a few years.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Kóczián Kristóf, the leader of the neuropsychiatry business unit, proudly stated that cariprazine became the 55th best-selling drug globally last year.
Index - Tudomány - Közel kétmillió ember életét változtatta meg egy magyar gyógyszer, és még csak tízévesIndex.hu·
Hungary· 2025-09-18
Hungary· 2025-09-18
